Cargando…

Methylation‐ and homologous recombination deficiency‐related mutant genes predict the prognosis of lung adenocarcinoma

BACKGROUND: Lung adenocarcinoma (LUAD) is a lung cancer subtype with poor prognosis. We investigated the prognostic value of methylation‐ and homologous recombination deficiency (HRD)‐associated gene signatures in LUAD. METHODS: Data on RNA sequencing, somatic mutations, and methylation were obtaine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nie, Guang‐Jie, Liu, Jian, Zou, Ai‐Mei, Zhan, Shao‐Feng, Liang, Jia‐Kang, Sui, Yi, Chen, Yu‐Ning, Yao, Wei‐Shen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8993616/ https://www.ncbi.nlm.nih.gov/pubmed/35238419 http://dx.doi.org/10.1002/jcla.24277

Ejemplares similares

Identification of immunotherapy biomarkers for improving the clinical outcome of homologous recombination deficiency patients with lung adenocarcinoma
por: Zhou, Xiang, et al.
Publicado: (2023)

Homologous recombination deficiency (HRD) score in aggressive prostatic adenocarcinoma with or without intraductal carcinoma of the prostate (IDC-P)
por: Zhu, Sha, et al.
Publicado: (2022)

Homologous Recombination Deficiencies and Hereditary Tumors
por: Yamamoto, Hideki, et al.
Publicado: (2021)

Biomarkers for Homologous Recombination Deficiency in Cancer
por: Wagener-Ryczek, Svenja, et al.
Publicado: (2021)

SLC26A4 correlates with homologous recombination deficiency and patient prognosis in prostate cancer
por: Luo, Cong, et al.
Publicado: (2022)

Pan-cancer landscape of homologous recombination deficiency
por: Nguyen, Luan, et al.
Publicado: (2020)

Determinants of Homologous Recombination Deficiency in Pancreatic Cancer
por: Wattenberg, Max M., et al.
Publicado: (2021)

Homologous Recombination Deficiency: Concepts, Definitions, and Assays
por: Stewart, Mark D, et al.
Publicado: (2022)

Targeting homologous recombination deficiency in uterine leiomyosarcoma
por: Dall, Genevieve, et al.
Publicado: (2023)

Leveraging homologous recombination repair deficiency in sarcoma
por: Slade, Dea, et al.
Publicado: (2023)

Homologous Recombination Deficiency (HRD) in Cutaneous Oncology
por: Akinjiyan, Favour A., et al.
Publicado: (2023)

Production of CFTR Mutant Gene Model by Homologous Recombination System
por: Rezaee, Hanieh, et al.
Publicado: (2022)

A transcriptional signature detects homologous recombination deficiency in pancreatic cancer at the individual level
por: Zhuang, Shuping, et al.
Publicado: (2021)

Signatures associated with homologous recombination deficiency and immune regulation to improve clinical outcomes in patients with lung adenocarcinoma
por: Shang, Xueqian, et al.
Publicado: (2022)

A Systematic Review and Meta-Analysis on the Prognostic Value of BRCA Mutations, Homologous Recombination Gene Mutations, and Homologous Recombination Deficiencies in Cancer
por: Shao, Changxia, et al.
Publicado: (2022)

Potential value of the homologous recombination deficiency signature we developed in the prognosis and drug sensitivity of gastric cancer
por: Wu, Xin, et al.
Publicado: (2022)

PARP targeting counteracts gliomagenesis through induction of mitotic catastrophe and aggravation of deficiency in homologous recombination in PTEN-mutant glioma
por: Majuelos-Melguizo, Jara, et al.
Publicado: (2014)

Homologous Recombination Repair Deficiency and Implications for Tumor Immunogenicity
por: van Wilpe, Sandra, et al.
Publicado: (2021)

The Utility of NGS Analysis in Homologous Recombination Deficiency Tracking
por: Tsantikidi, Aikaterini, et al.
Publicado: (2023)

High-Resolution Mapping of Homologous Recombination Events in rad3 Hyper-Recombination Mutants in Yeast
por: Andersen, Sabrina L., et al.
Publicado: (2016)

Partner Choice in Spontaneous Mitotic Recombination in Wild Type and Homologous Recombination Mutants of Candida albicans
por: Bellido, Alberto, et al.
Publicado: (2019)

Copy number alteration features in pan-cancer homologous recombination deficiency prediction and biology
por: Yao, Huizi, et al.
Publicado: (2023)

POLQ inhibition elicits an immune response in homologous recombination–deficient pancreatic adenocarcinoma via cGAS/STING signaling
por: Oh, Grace, et al.
Publicado: (2023)

Haploidization in Saccharomyces cerevisiae Induced by a Deficiency in Homologous Recombination
por: Song, Wei, et al.
Publicado: (2012)

Utility of Homologous Recombination Deficiency Biomarkers Across Cancer Types
por: Takamatsu, Shiro, et al.
Publicado: (2021)

Genomic Determinants of Homologous Recombination Deficiency across Human Cancers
por: Qing, Tao, et al.
Publicado: (2021)

Utility of Homologous Recombination Deficiency Biomarkers Across Cancer Types
por: Takamatsu, Shiro, et al.
Publicado: (2022)

Multi-scale characterisation of homologous recombination deficiency in breast cancer
por: Jacobson, Daniel H., et al.
Publicado: (2023)

Homologous Recombination Defective Arabidopsis Mutants Exhibit Enhanced Sensitivity to Abscisic Acid
por: Roy, Sujit, et al.
Publicado: (2017)

Prognosis of EGFR-mutant advanced lung adenocarcinoma patients with different intrathoracic metastatic patterns
por: Hu, Fang, et al.
Publicado: (2019)

Homologous recombination prevents methylation-induced toxicity in Escherichia coli
por: Nowosielska, Anetta, et al.
Publicado: (2006)

Homologous recombination deficiency in diverse cancer types and its correlation with platinum chemotherapy efficiency in ovarian cancer
por: Wen, Hao, et al.
Publicado: (2022)

Homologous recombination repair rathway and RAD54L in early-stage lung adenocarcinoma
por: Zheng, Shaopeng, et al.
Publicado: (2021)

Dynamically Accumulating Homologous Recombination Deficiency Score Served as an Important Prognosis Factor in High-Grade Serous Ovarian Cancer
por: Su, Rongjia, et al.
Publicado: (2021)

A 16-gene signature associated with homologous recombination deficiency for prognosis prediction in patients with triple-negative breast cancer
por: Wang, Daodu, et al.
Publicado: (2022)

CXCL10 potentiates immune checkpoint blockade therapy in homologous recombination-deficient tumors
por: Shi, Zhiwen, et al.
Publicado: (2021)

Intra-Tumoral CD8+ T-Cell Infiltration and PD-L1 Positivity in Homologous Recombination Deficient Pancreatic Ductal Adenocarcinoma
por: Golesworthy, Bryn, et al.
Publicado: (2022)

Homologous Recombination Pathway Alternation Predicts Prognosis of Colorectal Cancer With Chemotherapy
por: Lin, Yan, et al.
Publicado: (2022)

Homologous recombination-deficient tumors are hyper-dependent on POLQ-mediated repair
por: Ceccaldi, Raphael, et al.
Publicado: (2015)

Race-Specific Genetic Profiles of Homologous Recombination Deficiency in Multiple Cancers
por: Hsiao, Yi-Wen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4pkckgd054u391eq7k2m3hf2ib